LMR Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,839
| Closed | -$717K | – | 1624 |
|
|
2025
Q4 | $717K | Buy |
5,839
+3,269
| +127% | +$397K | ﹤0.01% | 1060 |
|
|
2025
Q3 | $285K | Sell |
2,570
-29,514
| -92% | -$3.35M | ﹤0.01% | 1171 |
|
|
2025
Q2 | $3.56M | Buy |
32,084
+18,162
| +130% | +$1.93M | 0.03% | 535 |
|
|
2025
Q1 | $1.56M | Sell |
13,922
-42,877
| -75% | -$4.42M | 0.01% | 703 |
|
|
2024
Q4 | $5.25M | Buy |
+56,799
| New | +$5.11M | 0.04% | 373 |
|
|
2023
Q1 | – | Sell |
-27,016
| Closed | -$2.32M | – | 1080 |
|
|
2022
Q4 | $2.32M | Buy |
+27,016
| New | +$2.14M | 0.04% | 478 |
|
|
2022
Q2 | – | Sell |
-39,437
| Closed | -$2.35M | – | 1352 |
|
|
2022
Q1 | $2.35M | Buy |
+39,437
| New | +$2.52M | 0.03% | 517 |
|
|
2021
Q4 | – | Sell |
-79,258
| Closed | -$5.54M | – | 1197 |
|
|
2021
Q3 | $5.54M | Buy |
+79,258
| New | +$5.57M | 0.06% | 232 |
|
|
2021
Q1 | – | Sell |
-12,240
| Closed | -$713K | – | 999 |
|
|
2020
Q4 | $713K | Sell |
12,240
-5,424
| -31% | -$327K | 0.01% | 316 |
|
|
2020
Q3 | $1.12M | Sell |
17,664
-58,638
| -77% | -$4.07M | 0.02% | 201 |
|
|
2020
Q2 | $5.87M | Buy |
76,302
+10,742
| +16% | +$823K | 0.15% | 93 |
|
|
2020
Q1 | $4.98M | Buy |
+65,560
| New | +$4.53M | 0.23% | 75 |
|
|
2019
Q4 | – | Sell |
-46,668
| Closed | -$2.96M | – | 455 |
|
|
2019
Q3 | $2.96M | Buy |
+46,668
| New | +$3.05M | 0.15% | 87 |
|
|
2017
Q3 | – | Sell |
-5,772
| Closed | -$409K | – | 404 |
|
|
2017
Q2 | $409K | Sell |
5,772
-38,168
| -87% | -$2.54M | 0.03% | 430 |
|
|
2017
Q1 | $2.98M | Buy |
+43,940
| New | +$3.09M | 0.29% | 66 |
|
|
2016
Q2 | – | Sell |
-5,373
| Closed | -$493 | – | 520 |
|
|
2016
Q1 | $493 | Buy |
+5,373
| New | +$485K | 0.05% | 273 |
|
|
2015
Q3 | – | Sell |
-18,989
| Closed | -$2.22M | – | 383 |
|
|
2015
Q2 | $2.22M | Sell |
18,989
-545
| -3% | -$59.6K | 0.27% | 93 |
|
|
2015
Q1 | $1.92M | Sell |
19,534
-15,152
| -44% | -$1.54M | 0.27% | 102 |
|
|
2014
Q4 | $3.27M | Buy |
+34,686
| New | +$3.59M | 0.43% | 41 |
|
|
2014
Q3 | – | Sell |
-61,051
| Closed | -$5.06M | – | 386 |
|
|
2014
Q2 | $5.06M | Buy |
+61,051
| New | +$4.75M | 0.42% | 49 |
|
Other funds holding GILD
VCM
VPM
LMR Partners's GILD Position: Q1 2026 in Review
LMR Partners sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 5,839 shares — an estimated $717K sold.
LMR Partners first reported a position in GILD in Q2 2014 and held it in 20 quarters. The position peaked at $5.87M in Q2 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- LMR Partners reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- LMR Partners sold 5,839 Gilead Sciences shares in Q1 2026, an estimated $717K.
- LMR Partners first reported a position in Gilead Sciences in Q2 2014 and held it in 20 quarters.
- LMR Partners's Gilead Sciences position peaked at $5.87M in Q2 2020.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.